LXRα would regulate hepatic peroxisomal fatty acid β-oxidation, and this process might be a counter regulatory mechanism for responding to extreme situations such as hypertriglyceridemia and liver steatosis [54]. This evidence concerns the gene NR1H3 and fatty liver disease.